Cell Microsystems develops and manufactures products for single-cell workflows, led by the CellRaft AIR System and CytoSort consumables. The System enables on-array image analysis and single-cell or clone isolation for CRISPR gene editing, clonal propagation, genomics, stem cell studies, organoids and other 3D cultures. Its products have been purchased by academic, government, and pharma research organizations across the U.S. and Europe. Following a $10M growth financing from Telegraph Hill Partners, the company will accelerate commercial activity, develop new products, and expand applications for single-cell characterization and isolation. Cell Microsystems plans to add hires in engineering, software systems, product applications, manufacturing, customer support, and commercial roles, significantly increasing headcount and capability. Telegraph Hill Partners will provide capital and strategic guidance, with THP partners joining the company's board to support expansion and commercial penetration.

Total raised

$10M

Funding rounds

1

Latest round

Equity

Latest activity

Nov 2021